Table 5.
Comparison of non-cardiac determinants of O2peak, and blood-based metabolic risk profile between Allo-SCT survivors and Controls.
| Allo-SCT survivors | Controls | P | |
|---|---|---|---|
| Non-cardiac determinants | |||
| Hemoglobin, g L−1 | 140.2 ± 12.5 | 141.8 ± 9.6 | 0.71 |
| Total LM, kg | 44.7 ± 7.9 | 49.0 ± 10.8 | 0.25 |
| Total FM, kg | 26.1 ± 8.9 | 20.3 ± 7.3 | 0.069 |
| Body fat percentage, % | 35.7 ± 7.1 | 27.8 ± 7.1 | 0.007 |
| SBP, mmHg | 127 ± 15 | 117 ± 15 | 0.11 |
| DBP, mmHg | 76 ± 10 | 70 ± 7 | 0.10 |
| a-vO2 difference, mL dL−1 | 11.7 ± 2.1 | 12.3 ± 1.5 | 0.34 |
| Blood-based metabolic risk profile | |||
| Total cholesterol, mmol L−1 | 5.1 ± 0.9 | 5.1 ± 0.9 | 0.95 |
| Triglycerides, mmol L−1 | 1.6 ± 0.7 | 1.2 ± 0.7 | 0.12 |
| HbA1c, % | 5.4 ± 0.2 | 5.3 ± 0.4 | 0.28 |
Data are mean ± SD; Abbreviations: a-vO2 difference arteriovenous oxygen difference, DBP diastolic blood pressure, FM fat mass, HbA1c glycated haemoglobin, LM lean mass, SBP systolic blood pressure